During a Senate Appropriations hearing, FDA commissioner Robert Califf tells lawmakers that the agency is advising against enriched enrollment studies...
FDA accepts for review a Bristol Myers Squibb BLA for a subcutaneous formulation of Opdivo (nivolumab) across all previously approved adult solid tumo...
FDA publishes a final guidance to clarify the distinctions between medical device remanufacturing and servicing.
A BMJ investigation looks at the relationship between several FDA commissioners and the companies the agency regulates.
FDA says Exocel Bio in San Diego is marketing unapproved exosome products.
Tandem Diabetes Care recalls its t:connect mobile app (version 2.7) on the Apple iOS platform that is used with the companys t:slim X2 insulin pump.
Federal Register notice: FDA announces a 6/4 Psychopharmacologic Drugs Advisory Committee meeting to discuss a Lykos Therapeutics NDA for midomafetami...
CBER director Peter Marks says FDA is working to achieve 90% correct decisions on gene therapy accelerated approvals.
